Sector consensus Black Diamond Therapeutics, Inc.
Stocks
BDTX
US09203E1055
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 1.960 USD | +1.55% |
|
-1.01% | -19.34% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 10 | +410.2% | 7 | |||||||
| 187.07 | +16.92% | 18 | |||||||
| 1,178.77 | +17.96% | 15 | |||||||
| 199.55 | +66.29% | 22 | |||||||
| 49.74 | +15.47% | 24 | |||||||
| 102.91 | +23.62% | 20 | |||||||
| 2,453.79 | +8.57% | 15 | |||||||
| 1,397.26 | +18.41% | 8 | |||||||
| 53.69 | -8.01% | 16 | |||||||
| 21.57 | +62.99% | 13 | |||||||
| 619.67 | +34.24% | 19 | |||||||
| 678.06 | +27.57% | 16 | |||||||
| 133.55 | +72.62% | 21 | |||||||
| 109.9 | +59.78% | 20 | |||||||
| 110 | +65.46% | 12 | |||||||
| 109 | +87.51% | 9 | |||||||
| 12.75 | +50.35% | 4 | |||||||
| 120.08 | +33.05% | 13 | |||||||
| 100.16 | +56.66% | 16 | |||||||
| 228.89 | +33.88% | 9 | |||||||
| Average | 393.82 | +57.68% | 15 | ||||||
| Weighted average by Cap. | 523.09 | +30.33% | 17 |
- Stock Market
- Stocks
- BDTX Stock
- Sector Black Diamond Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















